ReviewClinical pharmacology : advances and applications2025

Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine.

Irma Rahayu Latarissa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.